Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

RidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXD: medical device reports filed with FDA

414 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

414
device reports naming the brand
0% of all MAUDE reports · about 75 a year
50
reports, 12 months to August 2026
60 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

414 medical device reports received by FDA name the brand "RidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from January 2021 to July 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

50 reports arrived in the 12 months to August 2026, down 17% from 60 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (71.5%), loss of osseointegration (20.8%) and fracture (3.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01122Sep 2021: 2Oct 2021: 6Nov 2021: 6Dec 2021: 42022Jan 2022: 2Feb 2022: 18Mar 2022: 10Apr 2022: 0May 2022: 14Jun 2022: 8Jul 2022: 8Aug 2022: 4Sep 2022: 6Oct 2022: 8Nov 2022: 22Dec 2022: 82023Jan 2023: 8Feb 2023: 10Mar 2023: 8Apr 2023: 6May 2023: 16Jun 2023: 8Jul 2023: 8Aug 2023: 2Sep 2023: 6Oct 2023: 6Nov 2023: 8Dec 2023: 102024Jan 2024: 14Feb 2024: 20Mar 2024: 6Apr 2024: 6May 2024: 18Jun 2024: 2Jul 2024: 2Aug 2024: 4Sep 2024: 8Oct 2024: 10Nov 2024: 0Dec 2024: 42025Jan 2025: 0Feb 2025: 12Mar 2025: 4Apr 2025: 0May 2025: 0Jun 2025: 18Jul 2025: 2Aug 2025: 2Sep 2025: 8Oct 2025: 6Nov 2025: 4Dec 2025: 82026Jan 2026: 2Feb 2026: 2Mar 2026: 0Apr 2026: 2May 2026: 10Jun 2026: 2Jul 2026: 6Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0541082021: 2820212022: 10820222023: 9620232024: 9420242025: 6420252026: 242026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%414
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report50.5%209
Voluntary report0%0
User facility report0%0
Distributor report49.5%205
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate29671.5%62.8%
Loss of osseointegration8620.8%22.4%
Fracturea broken bone163.9%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis20148.6%
Painpain, site not specified13432.4%
Inflammationinflammation5814%
Hyperresponsive to stimuli378.9%
Swelling/ edema327.7%
Hemorrhage/blood loss/bleeding81.9%
Fistula61.4%
Abscessa collection of pus41%
Hypersensitivity/allergic reaction20.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureRidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXDProduct code DZEAll MAUDE reports
Reports4143,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer50.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about RidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXD reports

How many FDA reports name RidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXD?

414 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 50 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (71.5%), loss of osseointegration (20.8%) and fracture (3.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50.5%) and distributor reports (49.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that RidgeFit, ?2.4, GH2.8, SLA?, 10,TiN, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.